-
公开(公告)号:US12257348B2
公开(公告)日:2025-03-25
申请号:US17327724
申请日:2021-05-23
Applicant: Sol-Gel Technologies Ltd.
Inventor: Ofer Toledano , Karine Neimann , Danil Finkel-Moiseev , Maya Erlich , Dorit Marco
IPC: A61K9/48 , A61K9/00 , A61K9/50 , A61K31/202 , A61K31/203 , A61K31/235 , A61K31/327 , A61K31/336
Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
-
公开(公告)号:US12133919B2
公开(公告)日:2024-11-05
申请号:US17327729
申请日:2021-05-23
Applicant: Sol-Gel Technologies Ltd.
Inventor: Ofer Toledano , Karine Neimann , Danil Finkel-Moiseev , Maya Erlich , Dorit Marco
IPC: A61K9/48 , A61K9/00 , A61K9/50 , A61K31/202 , A61K31/203 , A61K31/235 , A61K31/327 , A61K31/336
Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
-
公开(公告)号:US11865100B2
公开(公告)日:2024-01-09
申请号:US17154689
申请日:2021-01-21
Applicant: Sol-Gel Technologies Ltd.
Inventor: Ofer Toledano , Ofra Levy-Hacham , Ori Nov , Vered Ram
CPC classification number: A61K31/327 , A61K9/0014 , A61K9/06 , A61K9/10 , A61K9/107 , A61K9/50 , A61P17/00 , A61P17/10
Abstract: A regimen for the therapeutic treatment of rosacea in subjects aged 65 years and older, the regimen comprising topically applying to the skin of a subject aged 65 years and older in need of said treatment a pharmaceutical composition, the pharmaceutical composition comprising about 1% w/w to about 10% w/w benzoyl peroxide as an active ingredient, and a pharmaceutically acceptable carrier or excipient, wherein the benzoyl peroxide is the only active ingredient in said pharmaceutical composition, wherein said pharmaceutical composition is applied once daily for a period of at least about 2 weeks, to achieve, in a group of such subjects, a success rate of at least about 15%, wherein the success rate is defined as the number of subjects achieving clear or almost clear skin on the investor global assessment (IGA) scale after treatment with the pharmaceutical composition.
-
公开(公告)号:US20210361586A1
公开(公告)日:2021-11-25
申请号:US17327724
申请日:2021-05-23
Applicant: Sol-Gel Technologies Ltd.
Inventor: Ofer Toledano , Karine Neimann , Danil Finkel-Moiseev , Maya Erlich , Dorit MARCO
IPC: A61K9/50 , A61K31/327 , A61K31/203 , A61K9/00
Abstract: The present application is directed to stabilized core-shell microcapsules comprising a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) and a metal-oxide shell; and to pharmaceutical compositions and methods of use thereof.
-
公开(公告)号:US10653899B2
公开(公告)日:2020-05-19
申请号:US16052635
申请日:2018-08-02
Applicant: SOL-GEL TECHNOLOGIES LTD.
Inventor: Ofer Toledano , Haim Bar-Simantov , Hanan Sertchook , Sharon Fireman-Shoresh , Dorit Marco
IPC: A01N25/28 , A61Q19/00 , B01J13/14 , A61K9/51 , A61K9/00 , A61K8/67 , A61K8/38 , A61K8/26 , A61K8/25 , A61K8/11 , A61K9/50 , A61K9/06 , A61K8/28 , A61K8/29 , A61K8/27 , A61K8/73 , A61K47/02 , A61K8/06 , F28D20/02
Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
-
公开(公告)号:US10420743B2
公开(公告)日:2019-09-24
申请号:US16033257
申请日:2018-07-12
Applicant: SOL-GEL TECHNOLOGIES LTD.
Inventor: Ofer Toledano , Ori Nov
IPC: A61K9/50 , A61K31/203 , A61K31/327 , A61P17/10 , A61K9/00
Abstract: The present application is directed to regimens, methods of treatment, and compositions for the treatment of acne in a subject suffering therefrom.
-
公开(公告)号:US20180117369A1
公开(公告)日:2018-05-03
申请号:US15834805
申请日:2017-12-07
Applicant: SOL-GEL TECHNOLOGIES LTD.
Inventor: Ofer Toledano , Haim Bar-Simantov , Hanan Sertchook , Sharon Fireman-Shoresh , Dorit Marco
IPC: A61Q19/00 , B01J13/14 , A61K9/51 , A61K8/11 , A61K8/67 , A61K8/38 , A61K8/26 , A61K8/25 , A61K9/00
CPC classification number: A61Q19/00 , A61K8/11 , A61K8/25 , A61K8/26 , A61K8/38 , A61K8/671 , A61K9/0014 , A61K9/5115 , A61K9/5192 , A61K2800/412 , B01J13/14
Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within a metal oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
-
公开(公告)号:US11628155B2
公开(公告)日:2023-04-18
申请号:US16794692
申请日:2020-02-19
Applicant: Sol-Gel Technologies Ltd.
Inventor: Ofer Toledano , Ori Nov
Abstract: A regimen and a pharmaceutical composition for the treatment of rosacea are described. The regimen includes topically applying to the skin of a subject in need of such treatment a pharmaceutical composition comprising about 1% w/w to about 10% w/w benzoyl peroxide as an active ingredient, and the pharmaceutically acceptable carrier or excipient, where the benzoyl peroxide is the only active ingredient in the pharmaceutical composition, and the pharmaceutical composition is a cream or an emulsion.
-
公开(公告)号:US20210290985A1
公开(公告)日:2021-09-23
申请号:US17340334
申请日:2021-06-07
Applicant: Sol-Gel Technologies Ltd.
Inventor: Ofer Toledano , Haim Bar-Simantov , Hanan Sertchook , Sharon Fireman-Shoresh , Dorit Marco
IPC: A61Q19/00 , B01J13/14 , A61K9/51 , A61K9/00 , A61K8/67 , A61K8/38 , A61K8/26 , A61K8/25 , A61K8/11 , A61K9/06 , A61K9/50 , B01J13/18 , F28D20/02 , A61K9/10
Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
-
公开(公告)号:US20200316005A1
公开(公告)日:2020-10-08
申请号:US16897308
申请日:2020-06-10
Applicant: SOL-GEL TECHNOLOGIES LTD.
Inventor: Ofer Toledano , Ori Nov
IPC: A61K31/203 , A61K9/00 , A61P17/10 , A61K9/50 , A61K31/327
Abstract: The present application is directed to regimens, methods of treatment, and compositions for the treatment of acne in a subject suffering therefrom.
-
-
-
-
-
-
-
-
-